PCCR-1 showed a concentration dependent inhibition of TCR stimulated IL-17 release from COPD lung BALf cells, PBMCs and whole blood, with potencies of 522.5 nM, 336.1 nM and 5053 nM respectively (Fig. 4B). The gene discussed is IL17A; the disease is chronic obstructive pulmonary disease.